QR056251 / Createrna - LARVOL DELTA

A Phase I clinical trial to evaluate the tolerance, safety, and pharmacokinetic characteristics of single and multiple oral administrations of QR056251 capsules in healthy adult Chinese subjects, as well as the effect of food on the pharmacokinetics of QR056251 capsules (ChiCTR) - P1 | N=68 | Recruiting | Sponsor: The Second Hospital of Anhui Medical University; The Second Hospital of Anhui Medical University

New P1 trial • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases